Close

Constellation Brands (STZ) PT Lowered to $258 at Morgan Stanley

Go back to Constellation Brands (STZ) PT Lowered to $258 at Morgan Stanley

Constellation Brands (STZ) PT Lowered to $234 at Deutsche Bank

July 3, 2018 7:21 AM EDT

Deutsche Bank lowered its price target on Constellation Brands (NYSE: STZ) to $234.00 (from $258.00) while maintaining a Buy rating.

Analyst Steve Powers said they came away from the Q1 results seeing less margin for error than previously anticipated and somewhat more concerned... More

Clouds Have Passed for Constellation Brands (STZ) - RBC

July 2, 2018 9:27 AM EDT

RBC Capital Nik Modi analyst said following Constellation Brands' (NYSE: STZ) miss, the "clouds have passed" and now they can "see the stars."

Modi said the miss was very much in line with the company's prior commentary. He said the top line remains... More

Constellation Brands (STZ) PT Lowered to $224 at Stifel

July 2, 2018 7:26 AM EDT

Stifel lowered its price target on Constellation Brands (NYSE: STZ) to $224.00 (from $230.00) while maintaining a Hold rating.

Analyst Mark Swartzberg lowers his forecasts citing higher beer costs and a discount to managers' win & spirit revenue along with the margin outlook.

... More

Pre-Open Movers 06/29: (GEMP) (DERM) (NKE) Higher; (PFIE) (STZ) (SNX) Lower (more...)

June 29, 2018 9:26 AM EDT

Today's Pre-Open Movers

Gemphire Therapeutics Inc. (NASDAQ: GEMP) 115.6% HIGHER; announced that it achieved the primary endpoint, reduction of TGs by gemcabene, in its Phase 2b INDIGO-1 trial in SHTG patients with baseline serum TGs >500 mg/dL.

Dermira, Inc. (NASDAQ: DERM) 25.7%... More

UPDATE: Constellation Brands (STZ) Misses Q1 EPS by 23c, Revenue About In-Line, Offers FY Guidance

June 29, 2018 7:35 AM EDT

(Updated - June 29, 2018 7:38 AM EDT)

Constellation Brands (NYSE: STZ) reported Q1 EPS of $2.20, $0.23 worse than the analyst estimate of $2.43. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.04 billion.

Constellation Brands sees FY19 comparable EPS of $9.40-$9.70 vs $9.73... More